Skip to Main Content

Article navigation

Drug Update| January 01 2007

Implementing Glucose Control Protocols in Critically Ill Patients

Gregory M. Susla, PharmD, FCCM

Gregory M. Susla, PharmD, FCCM

Gregory M. Susla is Associate Director, Medical Information, MedImmune, One MedImmune Way, Gaithersburg, MD 20878 (e-mail: suslag@medimmune.com).

Search for other works by this author on:

This Site

PubMed

Google Scholar

AACN Adv Crit Care (2007) 18 (1): 5–9.

https://doi.org/10.4037/15597768-2007-1001

You do not currently have access to this content.

Don't already have an account? Register